Industry Profile, 2009
Year: 2010") 2009") 2008") 2007") 2006") 2005") 2004") 2003") 2002") 2001") 2000") 1999") 1998")
Total for Pharmaceuticals/Health Products: $267,776,211
Total Number of Clients Reported: 446
Total Number of Lobbyists Reported: 1,733
. Campaign Contributions from this industry
|
Pharmaceutical Rsrch & Mfrs of America | $26,150,520 |
Pfizer Inc | $24,619,268 |
Amgen Inc | $12,440,000 |
Eli Lilly & Co | $11,215,000 |
GlaxoSmithKline | $8,760,000 |
Sanofi-Aventis | $8,352,000 |
Bayer AG | $8,318,512 |
Roche Holdings | $7,969,516 |
Biotechnology Industry Organization | $7,360,000 |
Johnson & Johnson | $6,560,000 |
Merck & Co | $6,410,000 |
Novartis AG | $6,195,670 |
AstraZeneca PLC | $5,932,000 |
Abbott Laboratories | $4,840,000 |
Medicines Co | $4,720,000 |
Medtronic Inc | $4,194,000 |
Baxter International | $4,050,000 |
Bristol-Myers Squibb | $3,811,256 |
Genzyme Corp | $3,617,000 |
Teva Pharmaceutical Industries | $3,340,000 |
Talecris Biotherapeutics | $2,950,000 |
CH Boehringer Sohn | $2,743,000 |
Eisai Co Ltd | $2,730,000 |
Merck KGaA | $2,380,000 |
Generic Pharmaceutical Assn | $2,178,807 |
Mylan Inc | $2,025,000 |
Boston Scientific Corp | $1,890,000 |
Schering-Plough Corp | $1,810,000 |
Covidien Ltd | $1,770,000 |
Endo Pharmaceuticals | $1,752,000 |
Novo Nordisk Pharmaceuticals | $1,725,000 |
Astellas Pharma USA | $1,701,408 |
Advanced Medical Technology Assn | $1,640,271 |
Takeda Pharmaceuticals America | $1,544,295 |
Celgene Corp | $1,365,000 |
Allergan Inc | $1,330,000 |
Gilead Sciences | $1,280,000 |
AmerisourceBergen Corp | $1,253,400 |
Amylin Pharmaceuticals | $1,250,000 |
Biogen Idec | $1,230,000 |
Millennium/Takeda Oncology Co | $1,180,000 |
Consumer Healthcare Products Assn | $1,162,220 |
Invacare Corp | $1,161,250 |
Watson Pharmaceuticals | $1,130,000 |
Genomic Health Inc | $1,100,000 |
Edwards Lifesciences | $1,077,127 |
McKesson Corp | $1,042,461 |
Academy of Managed Care Pharmacies | $1,005,000 |
COMMENTARY: $268 million. That's what Big Pharma paid lobbyists to influence Congress on their behalf. Now you know why there were so many problems getting healthcare reform passed.
Comments
You can follow this conversation by subscribing to the comment feed for this post.